Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -47.00% is 18% above its 5-year average of -57.17%, near the high end of its 5-year range (-318.79%–41.60%).
28.88% above its 12-month average of -66.08%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -67.17%.
EBITDA MARGIN
-47.00%
EBITDA MARGIN AVG TTM
-66.08%
EBITDA MARGIN AVG 3Y
-106.77%
EBITDA MARGIN AVG 5Y
-57.17%
EBITDA MARGIN AVG 10Y
-28.52%
EBITDA MARGIN AVG 15Y
-36.22%
EBITDA MARGIN AVG 20Y
-30.89%
CURRENT VS TTM AVG
+28.88%
CURRENT VS 3Y AVG
+55.98%
CURRENT VS 5Y AVG
+17.78%
CURRENT VS 10Y AVG
-64.79%
CURRENT VS 15Y AVG
-29.75%
CURRENT VS 20Y AVG
-52.17%
Codexis, Inc.
Market Cap
$149.51M
EBITDA Margin
-47.00%
TTM Avg
-66.08%
3Y Avg
-106.77%
5Y Avg
-57.17%
Market Cap
$152.16M
EBITDA Margin
-48812.58%
TTM Avg
-48812.58%
3Y Avg
-48812.58%
5Y Avg
-48812.58%
Market Cap
$146.66M
EBITDA Margin
-16238.30%
TTM Avg
-8929.91%
3Y Avg
-4730.54%
5Y Avg
-4730.54%
Market Cap
$153.84M
EBITDA Margin
-550.97%
TTM Avg
-275.49%
3Y Avg
-275.49%
5Y Avg
-275.49%
Market Cap
$143.81M
EBITDA Margin
-239.78%
TTM Avg
-210.59%
3Y Avg
-2213.91%
5Y Avg
-2345.87%
Market Cap
$142.49M
EBITDA Margin
-103.63%
TTM Avg
-143.63%
3Y Avg
-176.25%
5Y Avg
-194.05%
Market Cap
$142.11M
EBITDA Margin
-221.15%
TTM Avg
-221.15%
3Y Avg
-221.15%
5Y Avg
-221.15%
Market Cap
$138.26M
EBITDA Margin
-5.26%
TTM Avg
-11.06%
3Y Avg
-22.91%
5Y Avg
-20.50%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Codexis, Inc. (CDXS) | $149.51M | -47.00% | -66.08% | -106.77% | -57.17% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | -48812.58% | -48812.58% | -48812.58% | -48812.58% |
| Immuneering Corporation (IMRX)vs › | $146.66M | -16238.30% | -8929.91% | -4730.54% | -4730.54% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | -550.97% | -275.49% | -275.49% | -275.49% |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | -239.78% | -210.59% | -2213.91% | -2345.87% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -103.63% | -143.63% | -176.25% | -194.05% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -221.15% | -221.15% | -221.15% | -221.15% |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | -5.26% | -11.06% | -22.91% | -20.50% |
| Inogen, Inc. (INGN)vs › | $160.82M | -2.74% | -4.58% | -13.60% | -7.28% |
Gross Margin
83.7%
EBITDA Margin
-47.0%
Operating Margin
-54.5%
Net Margin
-39.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -67.17% |
| 2026-03-31 | -38.18% |
| 2025-12-31 | 41.60% |
| 2025-09-30 | -195.97% |
| 2025-06-30 | -70.68% |
| 2025-03-31 | -246.28% |
| 2024-12-31 | -24.46% |
| 2024-09-30 | -113.25% |
| 2024-06-30 | -259.18% |
| 2024-03-31 | -57.77% |
| 2023-12-31 | 8.49% |
| 2023-09-30 | -318.79% |
| 2023-06-30 | -46.33% |
| 2023-03-31 | -161.38% |
| 2022-12-31 | -34.82% |
| 2022-09-30 | -23.26% |
| 2022-06-30 | -0.16% |
| 2022-03-31 | -16.90% |
| 2021-12-31 | -34.94% |
| 2021-09-30 | 7.53% |
| 2021-06-30 | -12.22% |
| 2021-03-31 | -43.52% |
| 2020-12-31 | -13.01% |
| 2020-09-30 | -26.83% |
| 2020-06-30 | -33.41% |
| 2020-03-31 | -45.65% |
| 2019-12-31 | 1.40% |
| 2019-09-30 | 6.52% |
| 2019-06-30 | -44.83% |
| 2019-03-31 | -26.70% |
| 2018-12-31 | -1.92% |
| 2018-09-30 | -10.60% |
| 2018-06-30 | -26.39% |
| 2018-03-31 | -31.83% |
| 2017-12-31 | 5.18% |
| 2017-09-30 | -98.11% |
| 2017-06-30 | -59.04% |
| 2017-03-31 | -89.70% |
| 2016-12-31 | -46.14% |
| 2016-09-30 | 18.18% |
| 2016-06-30 | 22.19% |
| 2016-03-31 | -70.94% |
| 2015-12-31 | -7.97% |
| 2015-09-30 | 40.36% |
| 2015-06-30 | -72.00% |
| 2015-03-31 | -60.71% |
| 2014-12-31 | 13.56% |
| 2014-09-30 | -37.61% |
| 2014-06-30 | -106.64% |
| 2014-03-31 | -64.12% |
| 2013-12-31 | -77.39% |
| 2013-09-30 | -167.49% |
| 2013-06-30 | -141.44% |
| 2013-03-31 | -60.87% |
| 2012-12-31 | -161.99% |
| 2012-09-30 | 3.72% |
| 2012-06-30 | -9.29% |
| 2012-03-31 | -13.27% |
| 2011-12-31 | -5.67% |
| 2011-09-30 | 1.54% |
| 2011-06-30 | -9.63% |
| 2011-03-31 | -1.75% |
| 2010-12-31 | 7.70% |
| 2010-09-30 | -1.84% |
| 2010-06-30 | -5.51% |
| 2010-03-31 | 2.87% |
| 2009-12-31 | -12.49% |
| 2009-09-30 | -19.30% |
| 2009-06-30 | -5.42% |
| 2009-03-31 | -22.14% |
| 2008-12-31 | -27.78% |
| 2008-03-31 | -144.04% |
| 2007-03-31 | -103.74% |
